Mutations in the promoter region of the aldolase B gene that cause hereditary fructose intolerance
Corresponding Author
Erin M. Coffee
Molecular Biology, Cell Biology, and Biochemistry Program, Boston, MA, 02215 USA
Telephone: +617-353-5310, Fax: +617-358-0338, [email protected]
Search for more papers by this authorCorresponding Author
Dean R. Tolan
Molecular Biology, Cell Biology, and Biochemistry Program, Boston, MA, 02215 USA
Biology Department, Boston University, 5 Cummington Street, Boston, MA, 02215 USA
Telephone: +617-353-5310, Fax: +617-358-0338, [email protected]
Search for more papers by this authorCorresponding Author
Erin M. Coffee
Molecular Biology, Cell Biology, and Biochemistry Program, Boston, MA, 02215 USA
Telephone: +617-353-5310, Fax: +617-358-0338, [email protected]
Search for more papers by this authorCorresponding Author
Dean R. Tolan
Molecular Biology, Cell Biology, and Biochemistry Program, Boston, MA, 02215 USA
Biology Department, Boston University, 5 Cummington Street, Boston, MA, 02215 USA
Telephone: +617-353-5310, Fax: +617-358-0338, [email protected]
Search for more papers by this authorCommunicated by: Guy Besley
Competing interest: None declared
Electronic Supplementary Material:
The online version of this article (doi:10.1007/s10545-010-9192-5) contains supplementary material, which is available to authorized users.
Abstract
Hereditary fructose intolerance (HFI) is a potentially fatal inherited metabolic disease caused by a deficiency of aldolase B activity in the liver and kidney. Over 40 disease-causing mutations are known in the protein-coding region of ALDOB. Mutations upstream of the protein-coding portion of ALDOB are reported here for the first time. DNA sequence analysis of 61 HFI patients revealed single base mutations in the promoter, intronic enhancer, and the first exon, which is entirely untranslated. One mutation, g.−132G>A, is located within the promoter at an evolutionarily conserved nucleotide within a transcription factor-binding site. A second mutation, IVS1+1G>C, is at the donor splice site of the first exon. In vitro electrophoretic mobility shift assays show a decrease in nuclear extract-protein binding at the g.−132G>A mutant site. The promoter mutation results in decreased transcription using luciferase reporter plasmids. Analysis of cDNA from cells transfected with plasmids harboring the IVS1+1G>C mutation results in aberrant splicing leading to complete retention of the first intron (~5 kb). The IVS1+1G>C splicing mutation results in loss of luciferase activity from a reporter plasmid. These novel mutations in ALDOB represent 2% of alleles in American HFI patients, with IVS1+1G>C representing a significantly higher allele frequency (6%) among HFI patients of Hispanic and African-American ethnicity.
Supporting Information
Filename | Description |
---|---|
jimd0715-sup-0001.pdfPDF document, 80.6 KB | Construction of pProm2 for transient transfection assays A fragment of DNA from position –264 to +2870 and a fragment of DNA from position +4795 to +4890 were PCR amplified from wild-type DNA using primers with Xma I sites and Bgl II sites embedded within, respectively. Each fragment was digested with the appropriate restriction enzyme. The smaller, exon 2-containing fragment was cloned into pGL3-basic at the Bgl II site creating pGL3-100. The larger, promoter-containing fragment was cloned into pGL3-100 at the Xma I site creating pProm2. The G>A point mutant at g.–132 was introduced by site-directed mutagenesis creating p-132G>A |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- Abramoff MD, Magelhaes PJ, Ram SJ (2004) Image processing with image. J Biophoton Int, 11: 36–42.
- Ali M, Tunçman G, Cross N, et al (1994) Null alleles of the aldolase B gene in patients with hereditary fructose intolerance. J Med Genet, 31: 499–503, .
- Ali M, James CL, Cox TM (1996) A newly identified aldolase B splicing mutation (G– > C, 5′ intron 5) in hereditary fructose intolerance from New Zealand. Hum Mutat, 7: 155–157, .
- Anderson TA (1982) Recent trends in carbohydrate consumption. Annu Rev Nutr, 2: 113–132, .
- Baerlocher K, Gitzelmann R, Steinmann B, Gitzelmann-Cumarumsay N (1978) Hereditary fructose intolerance in early childhood: a major diagnostic challenge. Helv Paediatr Acta, 33: 465–487.
- Berardini T, Amsden AB, Penhoet EE, Tolan DR (1999) Identification of conserved promoter elements for aldB and isozyme specific residues in aldolase B. Comp Biochem Physiol, 122: 53–61.
10.1016/S0305-0491(98)10140-2 Google Scholar
- Brooks CC, Buist N, Tuerck J, Tolan DR (1991) Identification of a splice-site mutation in the aldolase B gene from an individual with hereditary fructose intolerance. Am J Hum Genet, 49: 1075–1081.
- Coffee EM, Yerkes L, Ewen EP, Zee T, Tolan DR (2009) Increased prevalence of mutant null alleles that cause hereditary fructose intolerance in the American population. J Inherit Metab Dis, 33: 33–42, .
- Cox TM (1988) Hereditary fructose intolerance. Quart J Med, 68: 585–594.
- Cox TM (1993) Iatrogenic deaths in hereditary fructose intolerance. Arch Dis Child, 69: 423–415, .
10.1136/adc.69.4.413 Google Scholar
- Cross NC, Cox TM (1990) Partial aldolase B gene deletions in hereditary fructose intolerance. Am J Hum Genet, 47: 101–106.
- Crossley M, Brownlee GG (1990) Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature, 345: 444–446, .
- Doyle SA, Tolan DR (1995) Characterization of recombinant human aldolase B and purification by metal chelate chromatography. Biochem Biophys Res Commun, 206: 902–908, .
- Esposito G, Santamaria R, Vitagliano L, et al (2004) Six novel alleles identified in Italian hereditary fructose intolerance patients enlarge the mutation spectrum of the aldolase B gene. Hum Mutat, 24: 534, .
- Faustino NA, Cooper TA (2003) Pre-mRNA splicing and human disease. Genes Dev, 17: 419–437, .
- Froesch ER, Wolf HP, Baitsch H, Prader A, Labhart A (1963) Hereditary fructose intolerance. An inborn defect of hepatic fructose-1-phosphate splitting aldolase. Am J Med, 34: 151–167, .
- Funari VA, Voevodski K, Leyfer D, Yerkes K, Cramer D, Tolan DR (2010) Quantitative gene-expression profiles in real time from expressed sequence tag database. Gene Expr, 14: 321–336, .
10.3727/105221610X12717040569820 Google Scholar
- Gitzelmann R, Baerlocher K (1973) Vorteile und Nachteile der Frucosein der Nahrung. Padiatr Fortbildungsk Prax, 37: 40–55.
- Gregori C, Ginot F, Decaux J-F, et al (1991) Expression of the rat aldolase B gene: a liver-specific proximal promoter and an intronic activator. Biochem Biophys Res Commun, 176: 722–729, .
- Gregori C, Kahn A, Pichard AL (1993) Competition between transcription factors HNF1 and HNF3, and alternative cell-specific activation by DBP and C/EBP contribute to the regulation of the liver-specific aldolase B promoter. Nucleic Acids Res, 21: 897–903, .
- Gregori C, Kahn A, Pichard AL (1994) Activity of the rat liver-specific aldolase B promoter is restrained by HNF3. Nucleic Acids Res, 22: 1242–1246, .
- Gregori C, Porteu A, Lopez S, Kahn A, Pichard AL (1998) Characterization of the aldolase B intronic enhancer. J Biol Chem, 273: 25237–25243, .
- Hers H-G, Joassin G (1961) Anomalie de l'aldolase hepatique dans l'intolerance au fructose. Enzymol Biol Clin, 1: 4–14.
- James CL, Rellos P, Ali M, Heeley AF, Cox TM (1996) Neonatal screening for hereditary fructose intolerance: frequency of the most common mutant aldolase B allele (A149P) in the British population. J Med Genet, 33: 837–841, .
- Koivisto UM, Palvimo JJ, Janne OA, Kontula K (1994) A single-base substitution in the proximal Sp1 site of the human low density lipoprotein receptor promoter as a cause of heterozygous familial hypercholesterolemia. Proc Natl Acad Sci USA, 91: 10526–10530, .
- Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet, 90: 41–54, .
- Laméire N, Mussche M, Baele G, Kint J, Ringoir S (1978) Hereditary fructose intolerance: a difficult diagnosis in the adult. Am J Med, 65: 416–423, .
- Lopez-Lastra M, Rivas A, Barria MI (2005) Protein synthesis in eukaryotes: the growing biological relevance of cap-independent translation initiation. Biol Res, 38: 121–146, .
- Malay AD, Procious SL, Tolan DR (2002) The temperature dependence of activity and structure for the most prevalent mutant aldolase B associated with hereditary fructose intolerance. Arch Biochem Biophys, 408: 295–304, .
- McGlincy NJ, Smith CW (2008) Alternative splicing resulting in nonsense-mediated mRNA decay: what is the meaning of nonsense?. Trends Biochem Sci, 33: 385–393, .
- Morris RCJ (1968) An experimental renal acidification defect in patients with hereditary fructose intolerance. II. Its distinction from classic renal tubular acidosis: its resemblance to the renal acidification defect associated with the Fanconi syndrome of children with cystinosis. J Clin Invest, 47: 1648–1663.
- Odièvre M, Gentil C, Gautier M, Alagille D (1978) Hereditary fructose intolerance in childhood: diagnosis, management and course in 55 patients. Am J Dis Child, 132: 605–608.
- Orkin SH, Alter BP, Altay C, et al (1978) Application of endonuclease mapping to the analysis and prenatal diagnosis of thalassemias caused by globin-gene deletion. New Engl J Med, 299: 166–172, .
- Park HD, Kim YK, Park KU, Kim JQ, Song YH, Song J (2009) A novel c.-22 T > C mutation in GALK1 promoter is associated with elevated galactokinase phenotype. BMC Med Genet, 10: 29, .
- Perez-Tur J, Froelich S, Prihar G, et al (1995) A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. NeuroReport, 7: 297–301.
- Raymondjean M, Pichard A-L, Gregori C, Ginot F, Kahn A (1991) Interplay of an original combination of factors: C/EBP, NFY, HNF3, and HNF1 in the rat aldolase B gene promoter. Nucleic Acids Res, 19: 6145–6153, .
- Saiki RK, Scharf S, Faloona F, et al (1985) Enzymatic amplification of b-globin genomic sequences and restriction analysis for diagnosis of sickle cell anemia. Science, 230: 1350–1354, .
- Sakai T, Ohtani N, McGee TL, Robbins PD, Dryja TP (1991) Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature, 353: 83–86, .
- Santer R, Rischewski J, vonWeihe M, et al (2005) The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe. Hum Mutat, 25: 594, .
- Silva AL, Romao L (2009) The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! which players make the decision?. FEBS Lett, 583: 499–505, .
- Steinmann B, Gitzelmann R (1981) The diagnosis of hereditary fructose intolerance. Helv Paediatr Acta, 36: 297–316.
- Steinmann B, Gitzelmann R, Van den Berghe G (2001) Disorders of fructose metabolism. In: C Scriver, A Beaudet, W Sly, D Valle, eds. The metabolic and molecular basis of inherited disease, New York: McGraw-Hill, 1489–1520.
- Tolan DR, Brooks CC (1992) Molecular analysis of common aldolase B alleles for hereditary fructose intolerance in North Americans. Biochem Mol Med, 48: 19–25.
- Tolan DR, Penhoet EE (1986) Characterization of the human aldolase B gene. Mol Biol Med, 3: 245–264.
- Tsutsumi K, Ito K, Ishikawa K (1989) Developmental appearance of transcription factors that regulate liver-specific expression of the aldolase B gene. Mol Cell Biol, 9: 4923–4931.
- Vallet V, Bens M, Antoine B, et al (1995) Transcription factors and aldolase B gene expression in microdissected renal proximal tubules and derived cell lines. Exp Cell Res, 216: 363–370, .
- Yabuki T, Ejiri S, Tsutsumi K (1993) Ubiquitous factors that interact simultaneously with two distinct cis-elements on the rat aldolase B gene promoter. Biochim Biophys Acta, 1216: 15–19.
- Yudkin J, Kang SS, Bruckdorfer KR (1980) Effects of high dietary sugar. Br Med J, 281: 1396, .